Quorum Health (QHC) EPS Estimated At $-0.39; 9 Analysts Are Bullish Fluor (FLR) Last Week

April 17, 2018 - By Vivian Park

Fluor Corporation (NYSE:FLR) Logo

Analysts expect Quorum Health Corporation (NYSE:QHC) to report $-0.39 EPS on May, 21.They anticipate $0.46 EPS change or 54.12% from last quarter’s $-0.85 EPS. After having $0.04 EPS previously, Quorum Health Corporation’s analysts see -1,075.00% EPS growth. The stock increased 0.44% or $0.04 during the last trading session, reaching $9.07. About 573,647 shares traded or 106.10% up from the average. Quorum Health Corporation (NYSE:QHC) has risen 20.72% since April 17, 2017 and is uptrending. It has outperformed by 9.17% the S&P500.

Among 19 analysts covering Fluor Corporation (NYSE:FLR), 9 have Buy rating, 0 Sell and 10 Hold. Therefore 47% are positive. Fluor Corporation had 59 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, February 19 by Macquarie Research. The stock of Fluor Corporation (NYSE:FLR) has “Hold” rating given on Friday, November 4 by Johnson Rice. Canaccord Genuity maintained Fluor Corporation (NYSE:FLR) on Monday, July 31 with “Buy” rating. The stock has “Outperform” rating by FBR Capital on Friday, July 31. The stock has “Buy” rating by Citigroup on Friday, December 9. The stock of Fluor Corporation (NYSE:FLR) has “Buy” rating given on Tuesday, September 19 by KeyBanc Capital Markets. The company was initiated on Wednesday, June 29 by M Partners. On Friday, November 3 the stock rating was maintained by Robert W. Baird with “Neutral”. The firm has “Buy” rating by Deutsche Bank given on Thursday, January 12. The firm has “Outperform” rating given on Wednesday, January 3 by Robert W. Baird. See Fluor Corporation (NYSE:FLR) latest ratings:

02/04/2018 Broker: Citigroup Rating: Buy Maintain
27/02/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $57 New Target: $62 Maintain
21/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $64.0 Maintain
22/02/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $71 New Target: $73 Maintain
21/02/2018 Broker: Alembic Rating: Hold
21/02/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $61 New Target: $64 Maintain
21/02/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $74 New Target: $75 Maintain
09/02/2018 Broker: KeyBanc Capital Markets Old Rating: Overweight New Rating: Overweight Old Target: $54 New Target: $61 Maintain
06/02/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $53 New Target: $74 Maintain
24/01/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $54 New Target: $57 Maintain

Among 8 analysts covering Quorum Health (NYSE:QHC), 0 have Buy rating, 2 Sell and 6 Hold. Therefore 0 are positive. Quorum Health had 11 analyst reports since May 16, 2016 according to SRatingsIntel. Avondale initiated the shares of QHC in report on Monday, May 23 with “Market Perform” rating. The stock of Quorum Health Corporation (NYSE:QHC) has “Underweight” rating given on Wednesday, June 7 by Morgan Stanley. RBC Capital Markets maintained Quorum Health Corporation (NYSE:QHC) rating on Friday, August 12. RBC Capital Markets has “Sector Perform” rating and $6 target. The firm has “Neutral” rating by Mizuho given on Monday, August 15. Mizuho initiated the shares of QHC in report on Monday, June 20 with “Neutral” rating. Deutsche Bank maintained it with “Hold” rating and $5 target in Wednesday, April 5 report. The company was downgraded on Thursday, August 11 by UBS. The firm has “Neutral” rating by UBS given on Friday, June 10. On Monday, May 16 the stock rating was initiated by Morgan Stanley with “Equal-Weight”. The firm has “Neutral” rating by Susquehanna given on Wednesday, June 8.

Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. The company has market cap of $273.93 million. The Company’s general hospital and outpatient healthcare services include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services. It currently has negative earnings. Quorum Health Corporation offers its healthcare services through its hospitals and affiliated facilities, including urgent care centers, diagnostic and imaging centers, physician clinics, and surgery centers.

The stock increased 1.22% or $0.71 during the last trading session, reaching $58.67. About 928,162 shares traded. Fluor Corporation (NYSE:FLR) has risen 8.50% since April 17, 2017 and is uptrending. It has underperformed by 3.05% the S&P500.

Fluor Corporation, through its subsidiaries, provides engineering, procurement, construction, fabrication and modularization, commissioning and maintenance, and project management services worldwide. The company has market cap of $8.21 billion. It operates through four divisions: Energy, Chemicals & Mining; Industrial, Infrastructure & Power; Maintenance, Modification & Asset Integrity ; and Government. It has a 43.14 P/E ratio. The Energy, Chemicals & Mining segment offers a range of design, engineering, procurement, construction, fabrication, and project management services to upstream, downstream, chemical, petrochemical, offshore and onshore gas and oil production, liquefied natural gas, pipeline, and metals and mining markets.

Investors sentiment increased to 0.83 in 2017 Q4. Its up 0.02, from 0.81 in 2017Q3. It increased, as 48 investors sold Fluor Corporation shares while 150 reduced holdings. 60 funds opened positions while 104 raised stakes. 118.31 million shares or 2.82% more from 115.07 million shares in 2017Q3 were reported. Afam Cap invested in 0.41% or 72,012 shares. Covington Cap Mngmt has invested 0.03% of its portfolio in Fluor Corporation (NYSE:FLR). Barrow Hanley Mewhinney And Strauss Lc reported 0% in Fluor Corporation (NYSE:FLR). 193,623 were reported by Citigroup. Manufacturers Life Co The holds 0.03% or 488,267 shares in its portfolio. Envestnet Asset Inc invested in 15,906 shares or 0% of the stock. Point72 Asset Mngmt L P holds 0.01% or 50,000 shares in its portfolio. Silvercrest Asset Management Gru has invested 0% in Fluor Corporation (NYSE:FLR). Paloma Prtnrs Mgmt Company has 0.01% invested in Fluor Corporation (NYSE:FLR). Qci Asset Management New York holds 0% of its portfolio in Fluor Corporation (NYSE:FLR) for 100 shares. Engines Ltd owns 17 shares. The Massachusetts-based Rampart Investment Mgmt Com Limited Liability Corp has invested 0.03% in Fluor Corporation (NYSE:FLR). 76,539 were accumulated by Hightower Advsr Limited Co. Financial Advisers Limited Liability accumulated 0% or 10,670 shares. Plante Moran Fincl Advsr Lc owns 248 shares.

Fluor Corporation (NYSE:FLR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: